Ticker Details
IDEAYA Biosciences, Inc.
IPO Date:	May 20, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.59B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 3.07%
Avg Daily Range (30 D):	$0.89 | 2.75%
Avg Daily Range (90 D):	$0.90 | 2.82%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	1.15M
Avg Daily Volume (90 D):	1.01M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	3,009
Avg Institutional Trade:	$2.48M
Avg Institutional Trade (30 D):	$2.91M
Avg Institutional Trade (90 D):	$2.81M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.56M
Avg Closing Trade (30 D):	$7.67M
Avg Closing Trade (90 D):	$6.46M
Avg Closing Volume:	129.83K

News

Apr 13, 2026 @ 11:48 AM IDEAYA Eye Cancer Trial Data Beats Standard Therap... Source: Vandana Singh

Dec 17, 2025 @ 3:00 PM Antibody Optimization Service Market Set to Reach ... Source: Towards Healthcare

Oct 14, 2025 @ 5:00 PM Melanoma Clinical Trial Pipeline Accelerates as 15... Source: Delveinsight

Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai

Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.58	$-1.11	$-.94
Diluted EPS	$-1.6	$-1.11	$-.94
Revenue	$225.27M	$6.56M	$10.88M
Gross Profit
Net Income / Loss	$-140.06M	$-98.54M	$-83.27M
Operating Income / Loss	$-183.47M	$-108.54M	$-94.57M
Cost of Revenue
Net Cash Flow	$28M	$44.96M	$-185.89M
PE Ratio